Insulin injections are not a cure. They only treat the surface symptoms of diabetes. Stem Cell Educator Therapy aims to fundamentally correct the autoimmune destruction of islet beta cells and improve the beta cell function.

Clinical trials reveal that a single treatment of Educator Therapy can provide a lasting reversal of autoimmunity that allows regeneration of islet beta cells and improvement of metabolic control in people with type 1 (T1D) and type 2 (T2D) diabetes. Even long standing participants with over 20 years of type 1 diabetes have demonstrated increased C-peptides, improved sugar control, and regenerated beta cells post treatment. Similar clinical data were achieved in long-standing (> 25 years) severe type 2 diabetic patients, with markedly improving islet beta-cell function after receiving one treatment with Educator therapy.

Multi-center clinical trials in the United States, China, and Spain have demonstrated the safety and efficacy of Educator Therapy in more than 500 participants (including T1D, T2D and other indications) spanning from 3 – 86 years old. In follow up studies, more than 70% of participants who underwent Educator Therapy showed significant, statistical improvement in their immune markers. This improvement was demonstrated by measuring Tregs, Th1/Th2 cytokines, and autoimmune memory T-cells. Notably, insulin dosages have been reduced or stopped in some patients.